Adrian has diverse experience and works for pharmaceutical and biotechnology companies, as well as medical device companies.
He has specific expertise in patent work relating to recombinant DNA technology, recombinant antibodies, gene therapy, diagnostic tests, screening methods and vaccines. Adrian also has experience with AI companies working in drug discovery. He has extensive experience of opposition and appeal procedures before the European Patent Office.
Adrian works with a number of universities as well as small and large biotechnology companies.
Adrian also takes a particular interest in Chinese patent law and is a regular visitor to China.
Education & background
Adrian has a degree in Genetics from Aberdeen University. He then went on to qualify as a patent attorney in 1998.
Adrian spent seven years in private practice with another firm of patent attorneys before joining Withers & Rogers in 2000.
Adrian currently heads up our Munich office and is closely involved with the European Patent Office. In particular, he is an associate member of the European Patent Institute biotechnology committee.
In March 2023, he was registered as a representative before the new Unified Patent Court, one of the first European patent attorneys to be entered on the list of UPC representatives.
